Ethinylestradiol/Drospirenone: A Review of its Use as an Oral Contraceptive

ISSN： 1175-6349

Source： Treatments in Endocrinology, Vol.2, Iss.1, 2003-01, pp. : 39-61

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

User Experience with an Oral Contraceptive Containing Ethinylestradiol 30g and Drospirenone 3mg (Yasmin ® ) in Clinical Practice

By Schultz-Zehden Beate

Treatments in Endocrinology, Vol. 5, Iss. 4, 2006-01 ,pp. : 251-256

Adis International

Access to resources Recommend Favorite

Influence of a new oral contraceptive with drospirenone on lipid metabolism

By Taneepanichskul Surasak Phupong Vorapong

Gynecological Endocrinology, Vol. 23, Iss. 6, 2007-06 ,pp. : 347-350

Informa Healthcare

Access to resources Recommend Favorite

Transdermal Ethinylestradiol/Norelgestromin: A Review of its Use in Hormonal Contraception

By Goa Karen L. Warner Gregory T. Easthope Stephanie E.

Treatments in Endocrinology, Vol. 2, Iss. 3, 2003-01 ,pp. : 191-206

Adis International

Access to resources Recommend Favorite

A Review of Transdermal Hormonal Contraception: Focus on the Ethinylestradiol/Norelgestromin Contraceptive Patch

By Graziottin Alessandra

Treatments in Endocrinology, Vol. 5, Iss. 6, 2006-01 ,pp. : 359-365

Adis International

Access to resources Recommend Favorite

Divergent effects of ethinylestradiol––drospirenone and flutamide––metformin on follistatin in adolescents and women with hyperinsulinemic androgen excess

By Ibááññez Lourdes Dííaz Marta Lóópez-Bermejo Abel de Zegher Francis

Gynecological Endocrinology, Vol. 27, Iss. 3, 2011-03 ,pp. : 197-198

Informa Healthcare

Access to resources Recommend Favorite